Peter Goldschmidt

Stada CEO Confirms Buyout Rumors, Sale Could Potentially Fetch $11B
BioSpace
Wed, 08/16/23 - 11:35 am
Stada
M&A
Peter Goldschmidt
Sandoz head sees biosimilars as the light in the generics storm
Fierce Pharma
Thu, 11/30/17 - 11:05 am
generics
biosimilars
Sandoz
Peter Goldschmidt